Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04112901
Other study ID # V1.2
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 15, 2020
Est. completion date May 30, 2020

Study information

Verified date September 2019
Source University of Derby
Contact Reza Safari, PhD.
Phone +441332592418
Email m.safari@derby.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

About 21% to 35% of people with limb loss are those who lost their limb at trans-femoral level (i.e. above the knee). The increasing number of diabetes-related limb loss (amputation) and the rising proportion of older adult amputees indicates more amputees with limited mobility in the future. Among other factors, prosthesis success highly depends on the function of the knee joints during daily activities.

Presently, there are two categories of prosthetic knee joints; microprocessor-controlled knees (MPKs) and non-microprocessor-controlled knees (n-MPKs). Whilst the n-MPKs are unable to change the knee stiffness, the MPKs alter the joint stiffness and speed of movement according to the users' walking speed.

Although past studies indicate that MPKs could result in reduced risk of falls, improved balance and activity in limited mobility amputees, there is a lack of strong evidence on the effect of MPKs on community outcomes. The aim of this study is to compare activity, mobility, social functioning, depression, anxiety, and health-related quality of life in limited mobility trans-femoral or through-knee (i.e. knee disarticulation) amputees who are users of MPKs prosthesis with users of a prosthesis with n-MPKs.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 330
Est. completion date May 30, 2020
Est. primary completion date May 1, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria:

- Unilateral transfemoral amputation or knee disarticulation

- = K2 mobility grade OR SIGAM grade D or below; i.e. able to walk = 50 meters on level ground,

- Users of either MPK or N-MPK for at least 6 months prior to the recruitment date.

Exclusion Criteria:

- Not meeting inclusion criteria

Study Design


Related Conditions & MeSH terms

  • People With Trans-femoral Amputation

Intervention

Device:
Microprocessor-controlled knee joints
Any type of microprocessor-controlled knee joints will be considered; this includes those controlling stance phase only (e.g. Compact C-Leg), swing phase only (e.g. Smart IP), both swing and stance phases (e.g. Reho knee), or power generating knees (e.g. POWER knee Ossur).
Non-microprocessor-controlled knee joints
Any non-microprocessor-controlled knee joints such as prosthesis incorporating hydraulic, polycentric, pneumatic mechanisms, friction or locked knees.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Derby

Outcome

Type Measure Description Time frame Safety issue
Primary Short Form-36 Quality of Life (SF-36) The SF-36 is a validated generic measure of health-related quality of life consisting of eight scales (physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions). Baseline
Secondary Special Interest Group in Amputee Medicine (SIGAM) SIGAM describe a single-item scale comprising six clinical grades (A -F) of amputee mobility. SIGAM is a self-report questionnaire with 21 dichotomous (Y/N) items and algorithm designed to facilitate grade assignment. Baseline
Secondary Prosthetic Evaluation Questionnaire (PEQ); Mobility, Social Burden and Residual Limb Health Subscales. These scales contain 22 questions (Mobility and transfer, n=13; social burden, n=3, residual limb health, n=6) using the visual analog scales. The PEQ is a valid and reliable measure of the prosthetic related quality of life. It consisted of nine sub-scales, which are not dependent on each other. Baseline
Secondary Reintegration to Normal Living Index (RNLI) RNLI measures the degree to which people with traumatic or incapacitating illness reintegrate into normal social activities (e.g. recreation, movement in the community, and interaction in the family or other relationships). Respondents rate 11 questions on Visual Analogue Scales. Baseline
Secondary Hospital Anxiety and Depression Scale (HADS) The HADS scale is used to measure the level of anxiety and depression a person experiencing. It comprises 14 items on the four-point Likert scale; Seven items on anxiety and seven items on depression. Baseline